NCT03617380 is a NA clinical trial of Usual Care in Disease, Chronic, sponsored by University of California, San Diego.

Who is sponsoring NCT03617380?

NCT03617380 is sponsored by University of California, San Diego.

What drugs are being tested in NCT03617380?

Interventions in NCT03617380: Usual Care, PharmD TOC.

What condition does NCT03617380 study?

NCT03617380 studies Disease, Chronic.

Is NCT03617380 still recruiting?

NCT03617380 is currently withdrawn. Last updated 12 February 2020.

Last reviewed 2020-02-12 · How we verify

NCT03617380

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

PharmD Transitions of Care Program (PHARMD-TOC): A Community Pharmacy Transitions of Care Program

Withdrawn NA Last updated 12 February 2020

What this trial tests

NA trial testing Usual Care in Disease, Chronic. Withdrawn.

Timeline

1 October 2018

Primary endpoint
10 February 2020

10 February 2020

Quick facts

Lead sponsor	University of California, San Diego
Phase	NA
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Start date	1 October 2018
Primary completion	10 February 2020
Estimated completion	10 February 2020

Drugs / interventions tested

Usual Care
PharmD TOC

Conditions studied

Disease, Chronic — all drugs for Disease, Chronic →

Sponsor

University of California, San Diego

Who can join

18 and older, any sex, with Disease, Chronic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Many hospitals and medical groups have developed transitions of care (TOC) programs or procedures in an attempt to reduce hospital readmission and reutilization rates of patients discharged from the hospital. As healthcare's most accessible practitioners, Community Pharmacists have a unique opportunity to assist with reducing unnecessary hospital re-utilization (re-admissions and emergency department visits) after hospital discharge. The purpose of this study is to conduct and evaluate the implementation of a Community Pharmacy-based Transitions of Care (TOC) Program for high-risk post-discharge patients of PIH Health Hospital-Whittier (PIH). The primary objective will be to compare the proportion of patients with hospital re-utilization (readmission, observation status, ED visits) during 30-days post hospital discharge between patients randomly assigned to the PHARMD-TOC group vs. the historic rate at PIH. Secondary analyses will examine differences between groups and describe implementation details of the PHARMD-TOC model of patient care.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Usual Care

Trials testing the same drug.

NCT07513805 — Implementation of Routine Walking Speed Measurements in Older Veterans · NA · not yet recruiting
NCT07225062 — Improving HIV Prevention and Substance Use Post-Sexual Assault Services · NA · not yet recruiting
NCT07202975 — RE-SCALE: Rehabilitation Engagement and Scaled Access With eXtended Reality and Artificial Intelligence · NA · not yet recruiting
NCT05744869 — SBAT for Health Equity · NA · not yet recruiting
NCT07380932 — Catheter Ablation for AF in Patients With Severe Mitral Regurgitation After Successful Transcatheter Mitral-Valve Repair · NA · not yet recruiting

Other University of California, San Diego trials

Trials by the same sponsor.

NCT07342543 — Guided Physical Activity Counseling for Hypertension in Primary Care · NA · not yet recruiting
NCT06505317 — Artificial Intelligence for Early Detection of Peripheral Artery Disease · NA · not yet recruiting
NCT07211802 — CKM For Safe Use of SGLT2i in Type 1 Diabetes · Phase 3 · not yet recruiting
NCT07524751 — Culturally Adapted Pain Management for Indigenous Peoples · NA · not yet recruiting
NCT07518784 — Accurate Point of Care Liver Disease Diagnostics (Phase 2) · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03617380 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of California, San Diego
Last refreshed: 12 February 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03617380.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing